Saks Samuel R 4
4 · Protagonist Therapeutics, Inc · Filed Feb 28, 2020
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-28+85,000→ 85,000 totalExercise: $7.80Exp: 2030-02-27→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 48 equal monthly installments following the date of grant.